Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Judy Ellen Garber, M.D.

Co-Author

This page shows the publications co-authored by Judy Garber and Sapna Syngal.
Connection Strength

2.139
  1. One less thing to worry about: the shrinking spectrum of tumors in BRCA founder mutation carriers. J Natl Cancer Inst. 2004 Jan 07; 96(1):2-3.
    View in: PubMed
    Score: 0.281
  2. Novel Models of Genetic Education and Testing for Pancreatic Cancer Interception: Preliminary Results from the GENERATE Study. Cancer Prev Res (Phila). 2021 11; 14(11):1021-1032.
    View in: PubMed
    Score: 0.241
  3. Sensitivity and specificity of clinical criteria for hereditary non-polyposis colorectal cancer associated mutations in MSH2 and MLH1. J Med Genet. 2000 Sep; 37(9):641-5.
    View in: PubMed
    Score: 0.223
  4. Phenotypic characteristics associated with the APC gene I1307K mutation in Ashkenazi Jewish patients with colorectal polyps. JAMA. 2000 Aug 16; 284(7):857-60.
    View in: PubMed
    Score: 0.222
  5. Interpretation of genetic test results for hereditary nonpolyposis colorectal cancer: implications for clinical predisposition testing. JAMA. 1999 Jul 21; 282(3):247-53.
    View in: PubMed
    Score: 0.206
  6. Precision Prevention and Early Detection of Cancer: Fundamental Principles. Cancer Discov. 2018 07; 8(7):803-811.
    View in: PubMed
    Score: 0.191
  7. Gastric cancer in individuals with Li-Fraumeni syndrome. Genet Med. 2011 Jul; 13(7):651-7.
    View in: PubMed
    Score: 0.118
  8. F18-fluorodeoxyglucose-positron emission tomography/computed tomography screening in Li-Fraumeni syndrome. JAMA. 2008 Mar 19; 299(11):1315-9.
    View in: PubMed
    Score: 0.094
  9. Prevalence of early onset colorectal cancer in 397 patients with classic Li-Fraumeni syndrome. Gastroenterology. 2006 Jan; 130(1):73-9.
    View in: PubMed
    Score: 0.081
  10. Comparison of motivations and concerns for genetic testing in hereditary colorectal and breast cancer syndromes. J Med Genet. 2004 Apr; 41(4):e44.
    View in: PubMed
    Score: 0.071
  11. Clinical presentation correlates with the type of mismatch repair gene involved in hereditary nonpolyposis colon cancer. Gastroenterology. 2004 Mar; 126(3):936-7.
    View in: PubMed
    Score: 0.071
  12. Cancer surveillance is often inadequate in people at high risk for colorectal cancer. J Med Genet. 2003 May; 40(5):e54.
    View in: PubMed
    Score: 0.067
  13. Clinical Implications of Pathogenic Germline Variants in Small Intestine Neuroendocrine Tumors (SI-NETs). JCO Precis Oncol. 2021 11; 5:808-816.
    View in: PubMed
    Score: 0.060
  14. Benefits of colonoscopic surveillance and prophylactic colectomy in patients with hereditary nonpolyposis colorectal cancer mutations. Ann Intern Med. 1998 Nov 15; 129(10):787-96.
    View in: PubMed
    Score: 0.049
  15. Impact of genetic testing on endometrial cancer risk-reducing practices in women at risk for Lynch syndrome. Gynecol Oncol. 2012 Dec; 127(3):544-51.
    View in: PubMed
    Score: 0.032
  16. Attitudes toward childbearing and prenatal testing in individuals undergoing genetic testing for Lynch syndrome. Fam Cancer. 2011 Sep; 10(3):549-56.
    View in: PubMed
    Score: 0.030
  17. Underutilization of BRCA1/2 testing to guide breast cancer treatment: black and Hispanic women particularly at risk. Genet Med. 2011 Apr; 13(4):349-55.
    View in: PubMed
    Score: 0.029
  18. Comprehensive molecular analysis of mismatch repair gene defects in suspected Lynch syndrome (hereditary nonpolyposis colorectal cancer) cases. Cancer Res. 2009 Sep 01; 69(17):7053-61.
    View in: PubMed
    Score: 0.026
  19. A hereditary nonpolyposis colorectal carcinoma case associated with hypermethylation of the MLH1 gene in normal tissue and loss of heterozygosity of the unmethylated allele in the resulting microsatellite instability-high tumor. Cancer Res. 2002 Jul 15; 62(14):3925-8.
    View in: PubMed
    Score: 0.016
  20. Evaluation of microsatellite instability and immunohistochemistry for the prediction of germ-line MSH2 and MLH1 mutations in hereditary nonpolyposis colon cancer families. Cancer Res. 2002 Jun 15; 62(12):3485-92.
    View in: PubMed
    Score: 0.016
  21. Germ-line msh6 mutations in colorectal cancer families. Cancer Res. 1999 Oct 15; 59(20):5068-74.
    View in: PubMed
    Score: 0.013
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.